Bank Julius Baer & Co. Ltd, Zurich Immunity Bio, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.67 - $10.18 $8,505 - $15,270	-1,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $265 - $412	29 Added 1.97%	1,500 $15,000
Q2 2021 Jul 23, 2021	SELL	$13.41 - $22.4 $388 - $649	-29 Reduced 1.93%	1,471 $21,000
Q1 2021 May 10, 2021	BUY	$12.83 - $42.25 $19,245 - $63,375	1,500 New	1,500 $36,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.